ウェアラブル注射器市場- 世界の産業規模、シェア、動向、機会、予測、タイプ別、技術別、用途別、地域別、競合別セグメント、2019-2029年

ウェアラブル注射器の世界市場規模は2023年に85億1,000万米ドルとなり、2029年までのCAGRは9.80%で、予測期間中に目覚ましい成長が見込まれています。

ウェアラブル注射器は、患者の体に装着したまま皮下または静脈注射で薬や治療物質を投与するように設計された革新的な医療機器です。これらのデバイスは、手動注射や静脈注射などの従来の注射方法と比較していくつかの利点があります。ウェアラブル注射器は、コンパクトで軽量であり、身体に装着するように設計されています。パッチタイプ、粘着タイプ、小型ポンプタイプなど様々な形状があり、目立たず快適に装着することができます。ウェアラブル注射器は主に、インスリン、生物学的製剤、化学療法薬、ホルモン、ワクチンなどを含むがこれらに限定されないドラッグデリバリーを制御し、正確に行うために使用されます。様々な粘度と容量の薬剤に対応できます。ウェアラブル注射器の重要な特徴の一つは、患者が自分で薬剤を投与できるようにすることです。患者自身が投薬の開始や管理を行うことができるため、頻繁にヘルスケア施設を訪れる必要がなくなります。

ウェアラブル注射器の中には、注射に伴う不快感を軽減し、患者の苦痛を軽減するマイクロニードルやその他の革新的な送達メカニズムを使用するものがあります。皮下または静脈内投与が必要な生物製剤や高分子薬剤の開発により、これらの特殊な薬剤を投与できるウェアラブル注射器の必要性が高まっています。ウェアラブル注射器とデジタルヘルスプラットフォームを統合することで、患者の服薬遵守と転帰をリアルタイムでモニタリングすることができます。この機能は、特にヘルスケアプロバイダーにとって、患者管理を強化するものとして価値があります。ウェアラブル注射器は、入院の必要性を減らし、手動注射に関連する合併症を最小限に抑えることで、コスト削減につながります。この費用対効果は、ヘルスケアプロバイダーや支払者にとって魅力的です。COVID-19の大流行は、遠隔ヘルスケアソリューションの採用を加速させました。ウェアラブル注射器は、患者に安全で快適な自宅での治療を提供する役割を担っています。

主な市場促進要因

技術革新

患者の自己管理志向の高まり

高齢化人口の増加

主な市場課題

コストと償還の問題

技術的な複雑さ

主な市場動向

在宅ヘルスケア

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 顧客の声

第5章 世界のウェアラブル注射器市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • タイプ別（オンボディ、オフボディ）
  • 技術別（スプリング式、モーター駆動式、ロータリーポンプ式、膨張式バッテリー、その他）
  • 用途別（腫瘍学、感染症、心血管疾患、自己免疫疾患、免疫不全症、その他）
  • 地域別
  • 企業別（2023）
• 市場マップ

第6章 アジア太平洋地域のウェアラブル注射器市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • タイプ別
  • 技術別
  • 用途別
  • 国別
• アジア太平洋地域：国別分析
  • 中国
  • インド
  • オーストラリア
  • 日本
  • 韓国

第7章 欧州のウェアラブル注射器市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • タイプ別
  • 技術別
  • 用途別
  • 国別
• 欧州：国別分析
  • フランス
  • ドイツ
  • スペイン
  • イタリア
  • 英国

第8章 北米のウェアラブル注射器市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • タイプ別
  • 技術別
  • 用途別
  • 国別
• 北米：国別分析
  • 米国
  • メキシコ
  • カナダ

第9章 南米のウェアラブル注射器市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • タイプ別
  • 技術別
  • 用途別
  • 国別
• 南米：国別分析
  • ブラジル
  • アルゼンチン
  • コロンビア

第10章 中東・アフリカのウェアラブル注射器市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • タイプ別
  • 技術別
  • 用途別
  • 国別
• 中東・アフリカ：国別分析
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦

第11章 市場力学

• 促進要因
• 課題

第12章 市場動向と発展

• 最近の動向
• 製品上市
• 合併と買収

第13章 ポーターのファイブフォース分析

• 業界内の競合
• 新規参入の可能性
• サプライヤーの力
• 顧客の力
• 代替品の脅威

第14章 競合情勢

• Beckton Dickinson & Co.
• Key Personnell Details
• Johnson & Johnson Service Inc.
• F. Hoffmann-La Roche Ltd.
• Frederick Furness Publishing Ltd
• Steady Med Therapeutics, Inc.（United Therapeutics Corporation）
• Amgen Inc.
• Insulet Corporation
• Enable Injections
• West Pharmaceutical Services, Inc.
• CeQur SA

第15章 戦略的提言

第16章 調査会社について・免責事項

Global Wearable Injectors Market was valued at USD 8.51 billion in 2023 and is anticipated to witness an impressive growth in the forecast period with a CAGR of 9.80% through 2029. Wearable injectors are innovative medical devices designed to administer medication or therapeutic substances through subcutaneous or intravenous injection while being worn on the patient's body. These devices offer several advantages over traditional injection methods, such as manual injections or intravenous infusions. Wearable injectors are compact, lightweight, and designed to be worn on the body. They can take various forms, such as patches, adhesive devices, or compact pumps, making them unobtrusive and comfortable to wear. Wearable injectors are primarily used for the controlled and precise delivery of medications, including but not limited to insulin, biologics, chemotherapy drugs, hormones, and vaccines. They can accommodate a range of drug viscosities and volumes. One of the key features of wearable injectors is their ability to empower patients to self-administer medications. Patients can initiate and control the delivery of their medications, reducing the need for frequent visits to healthcare facilities.

Some wearable injectors use micro-needles or other innovative delivery mechanisms that reduce the discomfort associated with injections, making the process less painful for patients. The development of biologics and large molecule drugs, which often require subcutaneous or intravenous administration, has driven the need for wearable injectors capable of delivering these specialized medications. The integration of wearable injectors with digital health platforms allows for real-time monitoring of patient adherence and outcomes. This feature is particularly valuable for healthcare providers, as it enhances patient management. Wearable injectors can lead to cost savings by reducing the need for hospital admissions and minimizing complications related to manual injections. This cost-effectiveness is appealing to healthcare providers and payers. The COVID-19 pandemic accelerated the adoption of remote healthcare solutions. Wearable injectors have played a role in providing treatments to patients in the safety and comfort of their homes.

Key Market Drivers

Technological Innovations

Wearable injectors have become smaller and more discreet, making them easier to wear and use. This miniaturization enhances patient comfort and convenience. Many wearable injectors now come equipped with connectivity features, enabling them to sync with smartphones or other electronic devices. This connectivity allows for remote monitoring, data collection, and real-time communication with healthcare providers. Manufacturers have developed companion smartphone apps that help patients manage their treatment regimens. These apps can provide reminders, track doses, and offer educational resources. Some wearable injectors include biometric sensors to monitor vital signs or biomarkers, allowing for a more personalized approach to drug delivery. These sensors can trigger drug administration when specific conditions are met. Innovations have improved the precision of drug delivery, ensuring that patients receive the exact dosage prescribed by their healthcare providers. This is particularly important for drugs with narrow therapeutic windows.

Needle-free or micro-needle systems reduce the discomfort associated with injections. These systems use innovative technologies like microneedles or high-velocity jets to deliver medication painlessly through the skin. Some wearable injectors incorporate proprietary microfluidic technology to deliver drugs with high accuracy and reliability while minimizing the risk of clogging or occlusion. Wearable injectors can be programmed to deliver medication at specific times and rates, tailored to an individual patient's needs. This level of customization enhances treatment effectiveness. Advanced algorithms can adapt drug delivery based on a patient's changing physiological conditions, improving safety and efficacy. For example, insulin pumps can adjust insulin delivery in response to blood glucose levels. Given the connectivity of many wearable injectors, data security and patient privacy are paramount. Innovations in this area include advanced encryption and authentication measures to protect patient information.

Many wearable injectors feature extended battery life to ensure uninterrupted drug delivery. Battery technology innovations have contributed to this improvement. The use of biocompatible materials in device construction minimizes the risk of adverse reactions, allergies, or skin irritations. Some wearable injectors can be remotely adjusted by healthcare providers, allowing for dose titration without requiring an in-person visit. Wearable injectors for diabetes management can integrate with Integration with Continuous Glucose Monitors (CGMs), providing a holistic approach to diabetes care by offering insulin delivery in response to real-time glucose data. AI algorithms and machine learning are being used to analyze patient data and make recommendations for optimized drug delivery and treatment plans. This factor will help in the development of the Global Wearable Injectors Market.

Increasing Patient Preference for Self-Administration

Patients appreciate the convenience of self-administration through wearable injectors. These devices are designed to be user-friendly, allowing patients to receive their medication without the need for frequent visits to healthcare facilities. Self-administration gives patients a sense of control and empowerment over their healthcare. It allows them to take an active role in managing their condition, which can lead to better treatment adherence and engagement. Wearable injectors reduce the burden on healthcare systems and providers. Patients can administer medication at home, reducing the strain on clinical resources, especially during periods of high patient demand. Self-administration through wearable injectors is less disruptive to a patient's daily routine. It eliminates the need for frequent injections or intravenous treatments, allowing individuals to lead more normal lives.

Some patients prefer to manage their healthcare in the privacy of their homes. Wearable injectors enable this by providing discreet and personal medication delivery. The shift towards patient-centered care emphasizes providing treatments that align with patients' preferences and lifestyles. Wearable injectors embody this approach by offering a patient-centric solution. Self-administration through wearable injectors can reduce the fear and anxiety associated with needles or injections. This is especially important for patients, such as children or those with needle phobias. In certain situations, self-administration can reduce the risk of healthcare-associated infections, making it a preferred option for some patients.

Wearable injectors with connectivity features can enable remote monitoring by healthcare providers. This provides patients with the confidence that they can receive support and adjustments to their treatment plans while self-administering. The convenience and comfort of self-administration often led to improved medication adherence. Patients are more likely to follow their prescribed treatment regimens when they can self-administer their medication with ease. The COVID-19 pandemic has accelerated the adoption of home-based and telehealth solutions. Wearable injectors align with this trend by allowing patients to receive treatments in the safety and comfort of their homes. This factor will pace up the demand of the Global Wearable Injectors Market.

Increasing Aging Population

As individuals age, they are more likely to develop chronic health conditions such as diabetes, cardiovascular diseases, and arthritis. Wearable injectors are commonly used to manage these long-term conditions, providing a convenient and efficient means of drug delivery. Many elderly individuals have complex medication regimens, often involving multiple medications taken at various times of the day. Wearable injectors simplify these regimens by automating drug delivery and reducing the need for multiple daily injections. Aging can lead to a decline in manual dexterity, making it difficult for older individuals to self-administer injections or manage traditional delivery methods. Wearable injectors offer an easier and less physically demanding solution. Some elderly patients may experience cognitive decline, which can lead to forgetfulness or medication errors. Wearable injectors with built-in reminders and automated dosing help mitigate these challenges.

Many older adults prefer to age in place, meaning they want to continue living in their homes rather than in assisted living facilities. Wearable injectors support this preference by allowing them to receive treatments while staying at home. Wearable injectors can enhance the quality of life for older adults by reducing the need for frequent medical appointments and hospital visits. They enable individuals to maintain a more independent and active lifestyle. Wearable injectors can ease the burden on caregivers and family members who often assist elderly patients with their treatments. These devices provide a level of autonomy for patients and reduce the reliance on caregivers. The integration of wearable injectors with telehealth and remote monitoring systems allows healthcare providers to keep a close eye on elderly patients' health, make necessary adjustments to treatment plans, and provide timely interventions.

Wearable injectors can be programmed to accommodate individualized drug delivery profiles, considering the specific needs and conditions of elderly patients. Wearable injectors can be used for preventative care as well, delivering vaccines or other preventive medications, which are crucial for aging populations susceptible to infections. Ensuring the accurate and consistent delivery of medications is vital for elderly patients, who may be at higher risk for medication-related adverse events. Wearable injectors offer a more reliable and safer delivery method. This factor will accelerate the demand of the Global Wearable Injectors Market.

Key Market Challenges

Cost and Reimbursement Issues

Wearable injectors can be relatively expensive to manufacture and purchase. The initial investment cost can be a barrier for both healthcare providers and patients, particularly in regions with limited healthcare budgets. Beyond the initial purchase, wearable injectors may entail ongoing maintenance costs for replacement parts, servicing, and support. These expenses can add to the overall cost of using these devices. In addition to the cost of the device itself, patients must also bear the cost of the medications delivered through wearable injectors. Some medications, particularly biologics, can be quite expensive. Reimbursement policies and mechanisms for wearable injectors vary from one healthcare system to another and can be complex. Ensuring that patients receive adequate reimbursement for the device and its associated costs can be a challenge. Patients may struggle to afford wearable injectors, even if they are the preferred method of drug delivery. The lack of affordable options can limit access to these devices for some individuals. Health insurance providers may offer inconsistent coverage for wearable injectors. Some insurers may fully cover the device and its associated costs, while others may only provide partial coverage or none.

Technical Complexities

Wearable injectors require intricate design and engineering to ensure that they are both reliable and user-friendly. Achieving the right balance between size, functionality, and ease of use can be technically challenging. Ensuring that wearable injectors are compatible with a wide range of medications, including biologics and high-viscosity drugs, can be technically complex. Different drugs may require unique delivery mechanisms, which can complicate device design. Precision in drug dosing is critical. Wearable injectors must deliver accurate and consistent doses, which can be challenging due to variations in drug properties, patient factors, and environmental conditions. Many wearable injectors incorporate connectivity features for remote monitoring and data collection. Ensuring the security of patient data and the reliability of data transmission can be technically demanding. Wearable injectors often rely on batteries for their operation. Extending battery life while maintaining device functionality can be technically complex. Efficient power management is essential. The integration of needles or micro-needles, as well as safety features to prevent needlestick injuries, can add technical complexity to device design and manufacturing.

Key Market Trends

Home Healthcare

The shift towards patient-centric care places greater emphasis on providing healthcare solutions that align with patients' preferences and lifestyles. Wearable injectors enable patients to receive treatments at home, promoting a more patient-centric approach. The aging population often prefers to age in place, meaning they want to stay in their homes rather than in healthcare facilities. Wearable injectors support this preference by allowing elderly patients to manage their healthcare at home. Many individuals with chronic conditions, such as diabetes, autoimmune diseases, or oncology, require ongoing treatment. Wearable injectors provide a convenient and effective means of managing these conditions from the comfort of one's home. Home healthcare, facilitated by wearable injectors, offers convenience and comfort. Patients can self-administer medications, reducing the need for frequent clinic visits, and enabling them to maintain their daily routines. Home healthcare with wearable injectors can lead to cost savings. It reduces the need for hospital admissions and minimizes complications related to manual injections, thus making healthcare more affordable for both patients and healthcare systems.

Segmental Insights

Type Insights

In 2023, the Global Wearable Injectors Market largest share was held by on-body segment and is predicted to continue expanding over the coming years. On-body wearable injectors are designed to be worn on the patient's body, offering convenience and comfort. Patients can go about their daily activities while receiving medication, as these devices are unobtrusive and do not require them to carry additional equipment. On-body wearable injectors are often used for continuous and controlled drug delivery. This is especially beneficial for chronic conditions that require regular dosing, such as diabetes or autoimmune disorders. Patients can receive their medication at scheduled intervals without the need for frequent injections. These devices reduce the need for patients to visit healthcare facilities for injections, which can be particularly important in situations where accessibility to healthcare services is limited, or during health crises such as the COVID-19 pandemic. On-body wearable injectors can enhance patient adherence to treatment regimens by simplifying the process. This can lead to improved treatment outcomes and a better quality of life for patients. On-body wearable injectors are often customizable to accommodate different drugs and dosages. This versatility allows them to address the diverse needs of patients with various medical conditions.

Application Insights

In 2023, the Global Wearable Injectors Market largest share was held by Oncology segment in the forecast period and is predicted to continue expanding over the coming years. Cancer is a leading cause of morbidity and mortality worldwide, and its incidence has been steadily increasing. As the global population ages and risk factors such as smoking and obesity persist, the demand for cancer treatments, including chemotherapy and targeted therapies, has risen. Many cancer treatments, especially for patients with advanced or recurring forms of cancer, require long-term and continuous drug administration. Wearable injectors are well-suited for these scenarios, as they provide a consistent and convenient means of drug delivery over an extended period. Cancer patients often undergo challenging and uncomfortable treatments. Wearable injectors can improve patient comfort by reducing the need for frequent hospital visits and intravenous infusions. This convenience can enhance patient compliance with their treatment plans. Wearable injectors can shift some of the treatment burden away from healthcare facilities. This is particularly important in oncology, where the demand for cancer treatment services can place a strain on healthcare systems and resources. Advances in precision medicine have led to more targeted and personalized cancer treatments. These treatments often involve highly specialized drugs that can be administered using wearable injectors, ensuring precise dosing and minimal disruption to the patient's daily life.

Regional Insights

The North America region dominates the Global Wearable Injectors Market in 2023. North America boasts highly advanced and well-developed healthcare infrastructure. This includes a robust network of healthcare providers, research institutions, and pharmaceutical companies. These organizations are often early adopters of new medical technologies, including wearable injectors. Chronic diseases such as diabetes, cardiovascular conditions, and autoimmune disorders are prevalent in North America. The convenience and improved disease management offered by wearable injectors make them particularly attractive in this region. North America is home to some of the world's largest pharmaceutical companies. These companies often invest in research and development, including the development of innovative drug delivery systems like wearable injectors. The United States, in particular, has one of the highest healthcare spending rates in the world. This allows for more significant investments in advanced medical technologies and easier access to expensive treatments like wearable injectors. While the regulatory process can be challenging, the United States and Canada have well-established regulatory frameworks for medical devices. This regulatory clarity can encourage manufacturers to seek approval for their wearable injector products in these markets.

Key Market Players

Becton & Dickinson Co.

Johnson & Johnson Service Inc.

F. Hoffmann-La Roche Ltd.

Frederick Furness Publishing Ltd

Steady Med Therapeutics, Inc (United Therapeutics Corporation)

Amgen Inc.

Insulet Corporation

Enable Injections

West Pharmaceutical Services, Inc.

CeQur SA

Report Scope:

In this report, the Global Wearable Injectors Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Wearable Injectors Market, By Type:

On-body Off-body

Wearable Injectors Market, By Technology:

Spring-based Motor-driven Rotary Pump Expanding Battery Other

Wearable Injectors Market, By Application:

Oncology Infectious Disease Cardiovascular Disease Autoimmune Disease Immunodeficiency Others

Wearable Injectors Market, By Region:

North America

United States

Canada

Mexico

Asia-Pacific

China

India

South Korea

Australia

Japan

Europe

Germany

France

United Kingdom

Spain

Italy

South America

Brazil

Argentina

Colombia

Middle East & Africa

South Africa

Saudi Arabia

UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Wearable Injectors Market.

Available Customizations:

Global Wearable Injectors Market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Wearable Injectors Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Type (On-body, Off-body)
  • 5.2.2. By Technology (Spring-based, Motor-driven, Rotary Pump, Expanding Battery, Other)
  • 5.2.3. By Application (Oncology, Infectious Disease, Cardiovascular Disease, Autoimmune Disease, Immunodeficiency, others)
  • 5.2.4. By Region
  • 5.2.5. By Company (2023)
• 5.3. Market Map

6. Asia Pacific Wearable Injectors Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Type
  • 6.2.2. By Technology
  • 6.2.3. By Application
  • 6.2.4. By Country
• 6.3. Asia Pacific: Country Analysis
  • 6.3.1. China Wearable Injectors Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Type
      • 6.3.1.2.2. By Technology
      • 6.3.1.2.3. By Application
  • 6.3.2. India Wearable Injectors Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Type
      • 6.3.2.2.2. By Technology
      • 6.3.2.2.3. By Application
  • 6.3.3. Australia Wearable Injectors Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Type
      • 6.3.3.2.2. By Technology
      • 6.3.3.2.3. By Application
  • 6.3.4. Japan Wearable Injectors Market Outlook
    • 6.3.4.1. Market Size & Forecast
      • 6.3.4.1.1. By Value
    • 6.3.4.2. Market Share & Forecast
      • 6.3.4.2.1. By Type
      • 6.3.4.2.2. By Technology
      • 6.3.4.2.3. By Application
  • 6.3.5. South Korea Wearable Injectors Market Outlook
    • 6.3.5.1. Market Size & Forecast
      • 6.3.5.1.1. By Value
    • 6.3.5.2. Market Share & Forecast
      • 6.3.5.2.1. By Type
      • 6.3.5.2.2. By Technology
      • 6.3.5.2.3. By Application

7. Europe Wearable Injectors Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Type
  • 7.2.2. By Technology
  • 7.2.3. By Application
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. France Wearable Injectors Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Type
      • 7.3.1.2.2. By Technology
      • 7.3.1.2.3. By Application
  • 7.3.2. Germany Wearable Injectors Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Type
      • 7.3.2.2.2. By Technology
      • 7.3.2.2.3. By Application
  • 7.3.3. Spain Wearable Injectors Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Type
      • 7.3.3.2.2. By Technology
      • 7.3.3.2.3. By Application
  • 7.3.4. Italy Wearable Injectors Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Type
      • 7.3.4.2.2. By Technology
      • 7.3.4.2.3. By Application
  • 7.3.5. United Kingdom Wearable Injectors Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Type
      • 7.3.5.2.2. By Technology
      • 7.3.5.2.3. By Application

8. North America Wearable Injectors Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Type
  • 8.2.2. By Technology
  • 8.2.3. By Application
  • 8.2.4. By Country
• 8.3. North America: Country Analysis
  • 8.3.1. United States Wearable Injectors Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Type
      • 8.3.1.2.2. By Technology
      • 8.3.1.2.3. By Application
  • 8.3.2. Mexico Wearable Injectors Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Type
      • 8.3.2.2.2. By Technology
      • 8.3.2.2.3. By Application
  • 8.3.3. Canada Wearable Injectors Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Type
      • 8.3.3.2.2. By Technology
      • 8.3.3.2.3. By Application

9. South America Wearable Injectors Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Type
  • 9.2.2. By Technology
  • 9.2.3. By Application
  • 9.2.4. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Wearable Injectors Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Type
      • 9.3.1.2.2. By Technology
      • 9.3.1.2.3. By Application
  • 9.3.2. Argentina Wearable Injectors Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Type
      • 9.3.2.2.2. By Technology
      • 9.3.2.2.3. By Application
  • 9.3.3. Colombia Wearable Injectors Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Type
      • 9.3.3.2.2. By Technology
      • 9.3.3.2.3. By Application

10. Middle East and Africa Wearable Injectors Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Type
  • 10.2.2. By Technology
  • 10.2.3. By Application
  • 10.2.4. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Wearable Injectors Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Type
      • 10.3.1.2.2. By Technology
      • 10.3.1.2.3. By Application
  • 10.3.2. Saudi Arabia Wearable Injectors Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Type
      • 10.3.2.2.2. By Technology
      • 10.3.2.2.3. By Application
  • 10.3.3. UAE Wearable Injectors Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Type
      • 10.3.3.2.2. By Technology
      • 10.3.3.2.3. By Application

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Developments
• 12.2. Product Launches
• 12.3. Mergers & Acquisitions

13. Porter's Five Forces Analysis

• 13.1. Competition in the Industry
• 13.2. Potential of New Entrants
• 13.3. Power of Suppliers
• 13.4. Power of Customers
• 13.5. Threat of Substitute Product

14. Competitive Landscape

• 14.1. Beckton Dickinson & Co.
  • 14.1.1. Business Overview
  • 14.1.2. Company Snapshot
  • 14.1.3. Products & Services
  • 14.1.4. Financials (In case of listed companies)
  • 14.1.5. Recent Developments
• 14.1.6 Key Personnell Details
  • 14.1.7. SWOT Analysis
• 14.2. Johnson & Johnson Service Inc.
• 14.3. F. Hoffmann-La Roche Ltd.
• 14.4. Frederick Furness Publishing Ltd
• 14.5. Steady Med Therapeutics, Inc. (United Therapeutics Corporation)
• 14.6. Amgen Inc.
• 14.7. Insulet Corporation
• 14.8. Enable Injections
• 14.9. West Pharmaceutical Services, Inc.
• 14.10.CeQur SA

15. Strategic Recommendations

16. About Us & Disclaimer